2022-RA-1367-ESGO Clinical and survival data of early-stage tubo-ovarian carcinoma according to BRCA mutational status. A large, multicenter, retrospective study

Marchetti, Cláudia; Ataseven, Beyhan; Perrone, Anna Myriam; Cassani, Chiara; Fruscio, Robert; Sassu, Carolina Maria; Apostol, Adriana Ionelia; Harter, Philipp; Traut, Alexander; Iaco, Pierandrea De; Arbustini, Eloisa; Bizzarri, Nicolò; Schneider, Stephanie; Rhiem, Kerstin; Stanislao, Marco Di; Urtis, Mario; Minucci, Angelo; Scambia, Giovanni; Fagotti, Anna

doi:10.1136/ijgc-2022-esgo.701

Search citation statements

Order By: Relevance

Paper Sections

Select...

Ovarian Cancer1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2022

Publication Types

Select...

Article1

Relationship

Self Cite1

Independent0

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Another presentation by Claudia Marchetti aimed to describe the impact of the BRCA status on the survival of patients with early-stage ovarian cancer 32. In a multicenter retrospective study the authors evaluated 369 patients—110 (29.8%) with BRCA mutation (BRCAm), and 259 (70.2%) BRCA wild-type (BRCAwt).…”

Section: Ovarian Cancermentioning

confidence: 99%

Best original research presented at the 23rd European Congress on Gynaecological Oncology—Best of ESGO 2022

Kacperczyk‐Bartnik

Bizzarri

Ángeles

et al. 2022

Int J Gynecol Cancer

Self Cite

View full text Add to dashboard Cite

Best of ESGO 2022 includes a selection of best original research presented during the 23rd European Congress on Gynaecological Oncology between October 27 and 30, 2022 in Berlin. Out of 1107 submitted abstracts, authors of studies which obtained the highest scores in a blinded review process were invited to present their results during four oral sessions, young investigators session, and oral poster sessions. By means of this publication, we aim to provide readers with an overview of the best quality research presented at the European Society of Gynaecological Oncology (ESGO) 2022.

show abstract

Section: Ovarian Cancermentioning

confidence: 99%